Oesophageal acid-peptic strictures in the histamine H2 receptor antagonist and proton pump inhibitor era

Digestive and Liver Disease

Volumn 35, Issue 3, 2003, Pages 143-150

  Nayyar, A K ^a,b   Royston, C ^a   Bardhan, K D ^a  

^a Rotherham NHS Foundation Trust   (United Kingdom)

^b DR RAM MANOHAR LOHIA HOSPITAL   (India)

Author keywords

Gastro oesophageal reflux disease; Oesophageal stricture

Indexed keywords

ACETYLSALICYLIC ACID; CIMETIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE; ANTIULCER AGENT; PROTON PUMP;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE SEVERITY; ENDOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS DILATATION; ESOPHAGUS STRICTURE; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDY; TREATMENT OUTCOME; BALLOON DILATATION; DRUG ANTAGONISM; ESOPHAGUS STENOSIS; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; ANTI-ULCER AGENTS; BALLOON DILATATION; ESOPHAGEAL STENOSIS; FEMALE; GASTROESOPHAGEAL REFLUX; HISTAMINE H2 ANTAGONISTS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OMEPRAZOLE; PROSPECTIVE STUDIES; PROTON PUMPS; RANITIDINE; TREATMENT OUTCOME;

EID: 0141545004     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(03)00021-5     Document Type: Article

References (34)

1. Bardhan K.D. Morris P. Thompson M. Dhande D.S. Hinchliffe R.F.C. Jones R.B. et al. Omeprazole in the treatment of erosive oesophagitis refractory to high dose cimetidine and ranitidine Gut 31 1990 745-749
2. Bardhan K.D. Cherian P. Jones R.B. Vaishnavi A. Manek S. Bishop A. et al. Histamine H2 receptor antagonist-refractory esophagitis: the efficacy of long-term omeprazole maintenance treatment Ital J Gastroenterol 29 1997 515-519
3. Holdsworth C.D. Atkinson M. Gastroenterology services: A regional review Br Med J 288 1984 1245-1247
4. Scott B. Atkinson M. Gastroenterology services: A regional review of changes over a 5-year period (1981-1986) Gut 30 1989 695-700
5. Scott B.B. Gastroenterology in the Trent Region in 1992 and a review of changes since 1975 Gut 36 1995 468-472
6. Ball C.S. Watson A. Acid sensitivity in reflux esophagitis with and without complications Gut 29 1988 A728
7. Volpicelli N.A. Bedine M.S. Hendrix T.R. Absence of acid sensitivity in patients with benign esophageal stricture Gastroenterology 68 1975 A1007
8. Marks R.D. Richter J.E. Rizzo J. Koehler R.E. Spenney J.G. Mills T.P. et al. Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis Gastroenterology 106 1994 907-915
9. Smith P.M. Kerr G.D. Cockel R. Ross B.A. Bate C.M. Brown P. et al. The Restore Investigator Group A comparison of omeprazole and ranitidine in the prevention of recurrence of benign esophageal stricture Gastroenterology 107 1994 1312-1318
10. Swarbrick E.T. Gough A.L. Foster C.S. Christian J. Garrett A.D. Langworthy C.H. Prevention of recurrence of esophageal stricture, a comparison of lansoprazole and high-dose ranitidine Eur J Gastroenterol Hepatol 8 1996 431-438
11. Benedict E.B. Peptic stenosis of the esophagus. A study of 223 patients treated with bougienage, surgery, or both Am J Dig Sci 11 1966 761-770
12. Ogilvie A.L. Ferguson R. Atkinson M. Outlook with conservative treatment of peptic esophageal stricture Gut 21 1980 23-25
13. Glick M.E. Clinical course of esophageal stricture managed by bougienage Dig Dis Sci 27 1982 884-888
14. Patterson D.J. Graham D.Y. Smith J.L. Schwartz J.T. Alpert E. Lanza F.L. et al. Natural history of benign esophageal stricture treated by dilatation Gastroenterology 85 1983 346-350
15. Hands L.J. Dennison A.R. Papavramidis S. McIntyre R.L. Bishop H. Kettlewell M.G.W. The natural history of peptic esophageal strictures treated by dilatation and antireflux therapy alone Ann R Coll Surg Engl 71 1989 306-309
16. Lanza F.L. Conservative management of esophageal stricture using dilatation and anti-reflux therapy South Med J 71 1978 8-9
17. Ferguson R. Dronfield M.W. Atkinson M. Cimetidine in the treatment of reflux esophagitis with peptic stricture Br Med J 2 1979 472-474
18. Farup P.G. Modalsli B. Tholfsen J.K. Long-term treatment with 300 mg ranitidine once daily after dilatation of peptic esophageal stricture Scand J Gastroenterol 27 1992 594-598
19. Starlinger M. Appel W.H. Schemper M. Schiesell R. Long-term treatment of peptic esophageal stenosis with dilatation and cimetidine: factors influencing clinical results Eur Surg Res 17 1985 207-214
20. Hine K.R. Rao K. Bari A. Lim A.G. Theodossi A. Famotidine in benign esophageal stricture. A double blind study Gastroenterology 104 1993 A100
21. Jasperson D. Diehl K.-L. Schoeppner H. Geyer P. Martens E. A comparison of omeprazole, lansoprazole and pantoprazole in the maintenance treatment of severe reflux oesophagitis Aliment Pharmacol Ther 12 1998 49-52
22. Barbezat G.O. Schulp M. Lubke R. Omeprazole therapy decreases the need for dilatation of peptic oesophageal strictures Aliment Pharmacol Ther 13 1999 1041-1045
23. Bardhan K.D. Is there any acid peptic disease that is refractory to proton pump inhibitors? Aliment Pharmacol Ther 7 1993 13-24
24. Heller S.R. Fellows I.W. Ogilvie A.L. Atkinson M. Non-steroidal anti-inflammatory drugs and benign esophageal stricture Br Med J 25 1982 167-168
25. Wilkins W.E. Ridley M.G. Pozniak A.L. Benign stricture of the esophagus: Role of non-steroidal anti-inflammatory drugs Gut 25 1984 478-480
26. Lanas A. Hirschowitz B.L. Significant role of aspirin use in patients with esophagitis J Clin Gastroenterol 13 1991 622-627
27. Brunner G.H.G. Lamberts R. Creutzfeldt W. Efficacy and safety of omeprazole in the long-term treatment of peptic ulcer and reflux esophagitis resistant to ranitidine Digestion 47 1990 64-68
28. Saeed Z.A. Graham D.Y. Treatment of benign esophageal strictures. Where do we go from here? Dig Dis Sci 39 1994 2099-3001
29. Earlam R. Cunha-Melo J.R. Benign esophageal strictures: Historical and technical aspects of dilatation Br J Surg 68 1981 829-836
30. Burkhart K.L. Sullivan B.H. Course and treatment of benign esophageal strictures Am J Gastroenterol 58 1972 531-536
31. Ugheoke E.A. Schaberg J.W. Philip S. Moloo J. Vasudeva R. Peptic esophageal strictures in the era of proton pump inhibitors: where have they all gone? Gastroenterology 116 1999 578
32. Bell N.J. Burget D. Howden C.W. Wilkinson J. Hunt R.H. Appropriate acid suppression for the management of gastroesophageal reflux disease Digestion 51 1992 56-67
33. Bardhan K.D. The role of proton pump inhibitors in the treatment of gastro-esophageal reflux disease Aliment Pharmacol Ther 9 1995 15-25
34. Penagini R. Al Dabbagh M. Misiewicz J.J. Evans P.F. Trotman I.F. Effect of dilatation of peptic esophageal strictures on gastroesophageal reflux, dysphagia and stricture diameter Dig Dis Sci 33 1988 389-392